Testing effectiveness (Phase 2)Ended earlyNCT05163717
What this trial is testing
INP105 Proof-of-concept Study for the Acute Treatment of Agitation in Adolescents and Young Adults With ASD
Who this might be right for
Agitation in Adolescents and Young Adults With ASD
Impel Pharmaceuticals 8